| PERIOD ENDING | 26-Dec-09 | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | | Total Revenue | 583,168 | 528,001 | 508,209 | 456,940 | | Cost of Revenue | 386,223 | 364,007 | 344,356 | 323,314 | | | Gross Profit | 196,945 | 163,994 | 163,853 | 133,626 | | | Operating Expenses | | Research Development | 20,735 | 18,497 | 21,886 | 17,889 | | Selling General and Administrative | 77,742 | 58,928 | 71,796 | 43,309 | | Non Recurring | 14,000 |
-
| 14,647 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 84,468 | 86,569 | 55,524 | 72,428 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,247 | (1,017) | 1,296 | (1,559) | | Earnings Before Interest And Taxes | 73,501 | 85,552 | 56,820 | 70,869 | | Interest Expense | (6,663) | 6,663 | 6,689 | 7,155 | | Income Before Tax | 80,164 | 78,889 | 50,131 | 63,714 | | Income Tax Expense | 26,928 | 17,864 | 17,851 | 17,847 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 53,236 | 61,025 | 32,280 | 45,867 | | | Non-recurring Events | | Discontinued Operations | (2,342) | 273 | 2,921 | 30 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 50,894 | 61,298 | 35,201 | 45,897 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $50,894 | $61,298 | $35,201 | $45,897 |
|
1.52% Nasdaq 0.00%
Income Statement
